PCSK9 inhibition: the road to effective management of high-risk patients.

About the speaker

Professor John Chapman

Sorbonne University, Paris (France)
15 presentations
0 follower

3 more presentations in this session

Welcome and introduction - PCSK9 inhibition: an important step forward in treating dyslipidemia in high-risk patients.

Speaker: Professor E. Stroes (Amsterdam, NL)

Thumbnail

Paving the way to a better future for high-risk patients.

Speaker: Professor K. Ray (London, GB)

Thumbnail

Closing remarks - PCSK9 inhibition: an important step forward in treating dyslipidemia in high-risk patients.

Speaker: Professor E. Stroes (Amsterdam, NL)

Thumbnail

Access the full session

PCSK9 inhibition: an important step forward in treating dyslipidemia in high-risk patients

Speakers: Professor J. Chapman, Professor E. Stroes, Professor K. Ray, Professor E. Stroes
Thumbnail

About the event

Image

ESC CONGRESS 2015

29 August - 2 September 2015

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk